Dostarlimab chemo combination for primary advanced or recurrent endometrial cancer

FolRα-targeting antibody drug conjugate shows promise in recurrent epithelial ovarian cancer

Next-generation selective RET inhibitor shows initial promise with RET-altered solid tumours

Trastuzumab deruxtecan gives strong anti-tumour activity and durable responses in multiple tumour types

Optimising cervical cancer care in Nigeria

Tackling low-volumes of clinical trials in Africa

The HypoAfrica study and AC3T research partnerships at NLCC

Achieving health equity in cancer care in the Philippines

Key practices for handling difficult conversations in cancer care

Choosing wisely in complementary treatment for cancer in the Philippines

A multidisciplinary team approach to cancer care in the Philippines

Choosing the right serum and molecular biomarkers in the Philippines